Pacira BioSciences Balance Sheet Health
Financial Health criteria checks 6/6
Pacira BioSciences has a total shareholder equity of $749.6M and total debt of $587.4M, which brings its debt-to-equity ratio to 78.4%. Its total assets and total liabilities are $1.5B and $772.1M respectively. Pacira BioSciences's EBIT is $102.0M making its interest coverage ratio -44.7. It has cash and short-term investments of $453.8M.
Key information
78.4%
Debt to equity ratio
US$587.36m
Debt
| Interest coverage ratio | -44.7x |
| Cash | US$453.81m |
| Equity | US$749.58m |
| Total liabilities | US$772.11m |
| Total assets | US$1.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 82P's short term assets ($690.0M) exceed its short term liabilities ($306.4M).
Long Term Liabilities: 82P's short term assets ($690.0M) exceed its long term liabilities ($465.7M).
Debt to Equity History and Analysis
Debt Level: 82P's net debt to equity ratio (17.8%) is considered satisfactory.
Reducing Debt: 82P's debt to equity ratio has reduced from 87.3% to 78.4% over the past 5 years.
Debt Coverage: 82P's debt is well covered by operating cash flow (34.7%).
Interest Coverage: 82P earns more interest than it pays, so coverage of interest payments is not a concern.